# Perioperative Dexmedetomidine on Postoperative Delirium in Patients With Brain Tumors

> **NCT06164314** · NA · RECRUITING · sponsor: **Beijing Tiantan Hospital** · enrollment: 366 (estimated)

## Conditions studied

- Postoperative Delirium

## Interventions

- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT06164314
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-25
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 366 (ESTIMATED)
- **Last updated:** 2025-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06164314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06164314, "Perioperative Dexmedetomidine on Postoperative Delirium in Patients With Brain Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06164314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*